Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for traumatic brain injury outcomes
IRCT20210113050023N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atorvastatin in traumatic brain injury (TBI) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Functional recovery rate. Started Apr 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20210113050023N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210113050023N1.